The study appears to be reporting at least a further 50% reduction in risk for previously infected people who get a vaccine. One might debate whether the proba

The study appears to be reporting at least a further 50% reduction in risk for previously infected people who get a vaccine. One might debate whether the probabilities involved are so low as to be irrelevant, but the study absolutely supports the existence of a benefit.